Board Meetings for JBCHEPHARM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited23 May 2011Audited Financial ResultsTo consider and approve annual audited financial results for the year ended on March 31, 2011.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited23 May 2011MiscelleneousAmongst other items, also consider reviewing its business in pharmaceutical products in so far as it relates to Russia-CIS countries and based on such review consider disinvestment of any such business or any part thereof (subject to all requisite approvals ) with a view to strengthening its Pharma business generally including its activities in India where the management believes there exits great potential for the company to strengthen its position.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited23 May 2011Results/DividendThe Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 23, 2011 to consider and approve annual audited financial results for the year ended on March 31, 2011. The Company has now informed the Exchange that the Board of Directors of the Company at the aforesaid meeting to be held on May 23, 2011 would also consider recommendation of dividend for the year 2010-11. (Purpose Revised).
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited13 Jan 2011Un-audited Financial ResultsTo approve and take on record the unaudited financial results for the quarter ended on December 31, 2010.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited26 Oct 2010Un-audited Financial ResultsTo approve and take on record the unaudited financial results for the quarter/half year ending on September 30, 2010.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited29 Jul 2010Un-audited Financial ResultsTo approve and take on record unaudited financial results for the quarter ended on June 30, 2010.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited05 May 2010Audited Financial Results and DividendTo consider and approve annual audited financial results for the year ended on March 31, 2010. Further, at the above referred meeting the Board of Directors would also consider recommendation of dividend for the year 2009-10.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited28 Jan 2010Unaudited Financial Results for the qtr ended Dec 31, 2009-
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited26 Oct 2009Unaudited Financial ResultsTo approve and take on record unaudited financial results for the quarter/half year ended on September 30, 2009.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited21 Jul 2009Unaudited Financial Results for the Qtr ended June 30, 2009-
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited12 May 2009Audited Financial Results and DividendTo consider and approve annual audited financial results for the year ended on March 31, 2009. Further, the board of directors at the above referred meeting would also consider recommendation of dividend for the year 2008-09.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited22 Jan 2009Unaudited Financial Results for the qtr ended Dec 31, 2008-
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited20 Oct 2008Unaudited Financial ResultsTo consider and to take on record the Unaudited Financial Results of the Company for the quarter/half year ended on September 30, 2008.
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited25 Jul 2008Unaudited Financial Results for the Qtr ended June 30, 2008-
-
JBCHEPHARMJB Chemicals & Pharmaceuticals Limited04 Jul 2008Buy backThe Company has informed the Exchange that at its Board Meeting held on April 8, 2008, the Board had approved, in principle, a Buy-Back of the Company's own shares up to the limit specified therein and providing for the ceiling rate at which such Buy-Back may be made. Following the reported view expressed by Securities & Exchange Board of India to the effect that even a Buy-Back by the Company can result in an increase in the Promoters' interest only if the same is exempted under the Take-over Code, the Special Committee appointed by the Board for the purpose of Buy-Back initiated steps to seek such exemption which process, however, is still not complete. In the meantime, having regard to the lapse of almost 3 months as also to the very material changes that have taken place in the Equity Markets in India, the Board has been advised to convene a meeting of the Special Committee and following that meeting, a meeting of the Board of Directors to review the situation in all aspects with a view to ensuring that the basic objective of the Buy-Back, namely, to enhance the shareholder value, is achieved. Accordingly, a meeting of the Special Committee has been convened on July 4, 2008 at 10.00 a.m. and a meeting of the Board of Directors is to be held at 11.30 am (or as soon as the meeting of the Special Committee is concluded if it goes beyond 11:30 a.m.) to review the matter.
-
Showing page 7 of 9 (122 total items)